Tavotek realizes that collaboration to leverage the best resources and technology of external partners are important. Accordingly, it has actively sought external partnerships and collaborations with other biotech companies, academic centers, and research institutes worldwide.
The first among these efforts is the strategic research alliances it formed in January 2020 with YiSheng BioPharma. Yisheng is a 500-employee biopharmaceutical company with offices in Asia and US. It is in the business of discovering, developing, and commercializing biotherapeutics for cancer and infectious disease using its novel PIKA® immunomodulating technology. The company currently has two marketed products in China and the South Asia market.
Many other partnership and collaboration are being developed and would be announced as they become available.
Copyright © 2020 Tavotek Biotherapeutics - All Rights Reserved.